European Commission logo
English English
CORDIS - EU research results

Personalised Health cognitive assistance for RehAbilitation SystEm

Project description

Individualised intervention for post-stroke rehabilitation

The prevalence of stroke places a huge clinical, economic, and societal burden worldwide. Impairments, particularly in the upper limb, and cognitive and communication functions are main causes of disability post-stroke. While rehabilitation can help reduce impairments, the path to recovery includes several gaps in treatment and information. Moreover, rehabilitation programmes are not available to all patients, and traditional approaches do not leverage patient data across the clinical path. The EIC-founded PHRASE project will create a data pipeline that integrates the best available scientific knowledge to ensure the most efficient prognosis and intervention protocols for stroke and brain-related diseases. The overall goal is to develop prognosis and intervention solutions that maximise patient outcomes, democratise accessibility to care, and reduce healthcare costs.


Stroke-caused cognitive and neuromotor impairment is currently an increasing burden: post-stroke deficits are commonly believed to be treated with rehabilitation. Direct medical costs of stroke are stimated to increase up to 94.3 billion USD only in US. The indirect costs, including non-healthcare costs, are estimated at 15.9 billion. The journey towards recovery includes several stages, from hospitalization to in-patient and out-patient rehabilitation and the subsequent return to home. Not everyone has access to rehabilitation programs, and the gains of them tend to deteriorate after hospital discharge. Focused stroke rehabilitation reduces long-term disability and the economic burden of stroke and supports prevention by lessening modifiable risks. The objective of PHRASE (Personalised Health cognitive assistance for RehAbilitation SystEm) is to create a workflow that integrates the best available scientific knowledge and obtain an efficient prognosis and intervention protocols for stroke and other brain-related diseases. It will not only allow to treat stroke-caused impairments better and more efficiently, but also it is a potential treatment for other neurological diseases like dementia, aphasia and PSCI, depression or multiple sclerosis. Eodyne's PHRASE will be based on RGS previous technology, developing its Technology Readiness Level. The present consortium brings together a comprehensive group of highly qualified experts. So that Eodyne can successfully produce prognosis and intervention individualized protocols, EBRAINS will be the brain database and Charité will provide with its brain models for the combination of data brain. SPECS-Lab will bring its knowledge in cognitive rehabilitation and will act as clinical coordinator, while Saddlepoint Science brings the expertise to implement the AI tools for continuous improvement of the intervention protocols.


Net EU contribution
€ 1 226 890,00
08019 Barcelona

See on map


The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Total cost
€ 1 226 890,00

Participants (4)